376 related articles for article (PubMed ID: 27085782)
1. Impaired insulin action in the liver, but not in adipose tissue or muscle, is a distinct metabolic feature of impaired fasting glucose in obese humans.
Ter Horst KW; Gilijamse PW; Ackermans MT; Soeters MR; Nieuwdorp M; Romijn JA; Serlie MJ
Metabolism; 2016 May; 65(5):757-763. PubMed ID: 27085782
[TBL] [Abstract][Full Text] [Related]
2. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis.
Bock G; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Chandramouli V; Landau BR; Rizza RA
Diabetes; 2007 Jun; 56(6):1703-11. PubMed ID: 17384334
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of prediabetes: role of the liver in isolated fasting hyperglycemia and combined fasting and postprandial hyperglycemia.
Basu R; Barosa C; Jones J; Dube S; Carter R; Basu A; Rizza RA
J Clin Endocrinol Metab; 2013 Mar; 98(3):E409-17. PubMed ID: 23345093
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance in obesity can be reliably identified from fasting plasma insulin.
ter Horst KW; Gilijamse PW; Koopman KE; de Weijer BA; Brands M; Kootte RS; Romijn JA; Ackermans MT; Nieuwdorp M; Soeters MR; Serlie MJ
Int J Obes (Lond); 2015 Dec; 39(12):1703-9. PubMed ID: 26155920
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of prediabetes in a Swedish cohort of severely obese children.
Ek AE; Rössner SM; Hagman E; Marcus C
Pediatr Diabetes; 2015 Mar; 16(2):117-28. PubMed ID: 24635861
[TBL] [Abstract][Full Text] [Related]
6. Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism.
Daniele G; Winnier D; Mari A; Bruder J; Fourcaudot M; Pengou Z; Tripathy D; Jenkinson C; Folli F
Diabetes Care; 2015 Aug; 38(8):1509-17. PubMed ID: 26084344
[TBL] [Abstract][Full Text] [Related]
7. Insulin sensitivity and metabolic flexibility following exercise training among different obese insulin-resistant phenotypes.
Malin SK; Haus JM; Solomon TP; Blaszczak A; Kashyap SR; Kirwan JP
Am J Physiol Endocrinol Metab; 2013 Nov; 305(10):E1292-8. PubMed ID: 24064339
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.
Bock G; Dalla Man C; Campioni M; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Rizza R
Diabetes; 2006 Dec; 55(12):3536-49. PubMed ID: 17130502
[TBL] [Abstract][Full Text] [Related]
9. The potential role of the osteopontin-osteocalcin-osteoprotegerin triad in the pathogenesis of prediabetes in humans.
Daniele G; Winnier D; Mari A; Bruder J; Fourcaudot M; Pengou Z; Hansis-Diarte A; Jenkinson C; Tripathy D; Folli F
Acta Diabetol; 2018 Feb; 55(2):139-148. PubMed ID: 29151224
[TBL] [Abstract][Full Text] [Related]
10. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
11. Glucose-Mediated Glucose Disposal at Baseline Insulin Is Impaired in IFG.
Alatrach M; Agyin C; Mehta R; Adams J; DeFronzo RA; Abdul-Ghani M
J Clin Endocrinol Metab; 2019 Jan; 104(1):163-171. PubMed ID: 30371795
[TBL] [Abstract][Full Text] [Related]
12. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
[TBL] [Abstract][Full Text] [Related]
13. Sexual Dimorphism in Hepatic, Adipose Tissue, and Peripheral Tissue Insulin Sensitivity in Obese Humans.
Ter Horst KW; Gilijamse PW; de Weijer BA; Kilicarslan M; Ackermans MT; Nederveen AJ; Nieuwdorp M; Romijn JA; Serlie MJ
Front Endocrinol (Lausanne); 2015; 6():182. PubMed ID: 26635731
[TBL] [Abstract][Full Text] [Related]
14. Impaired insulin sensitivity is accompanied by disturbances in skeletal muscle fatty acid handling in subjects with impaired glucose metabolism.
Moors CC; van der Zijl NJ; Diamant M; Blaak EE; Goossens GH
Int J Obes (Lond); 2012 May; 36(5):709-17. PubMed ID: 21712806
[TBL] [Abstract][Full Text] [Related]
15. Hepatic glucose sensing is impaired, but can be normalized, in people with impaired fasting glucose.
Perreault L; Færch K; Kerege AA; Bacon SD; Bergman BC
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1154-62. PubMed ID: 24731008
[TBL] [Abstract][Full Text] [Related]
16. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
[TBL] [Abstract][Full Text] [Related]
17. Altered Skeletal Muscle Fatty Acid Handling in Subjects with Impaired Glucose Tolerance as Compared to Impaired Fasting Glucose.
Goossens GH; Moors CC; Jocken JW; van der Zijl NJ; Jans A; Konings E; Diamant M; Blaak EE
Nutrients; 2016 Mar; 8(3):164. PubMed ID: 26985905
[TBL] [Abstract][Full Text] [Related]
18. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
Kruszynska YT; Olefsky JM; Frias JP
Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
[TBL] [Abstract][Full Text] [Related]
19. From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation.
Bacha F; Lee S; Gungor N; Arslanian SA
Diabetes Care; 2010 Oct; 33(10):2225-31. PubMed ID: 20592052
[TBL] [Abstract][Full Text] [Related]
20. Glucoregulatory physiology in subjects with low-normal, high-normal, or impaired fasting glucose.
Dagogo-Jack S; Askari H; Tykodi G
J Clin Endocrinol Metab; 2009 Jun; 94(6):2031-6. PubMed ID: 19276238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
